Eli Lilly and Company

Eli Lilly and Company is a US pharmaceutical company based in Indianapolis, Indiana. Its shares trade on the NYSE under the ticker LLY. The company operates with an integrated structure that runs from drug discovery through clinical research to manufacturing.

At the center of its portfolio is tirzepatide, which mimics the effect of incretin hormones; the active ingredient is used to treat diabetes under the Mounjaro brand and for weight management under the Zepbound brand. The company also has products such as Verzenio in oncology, Taltz and Ebglyss in immunology, and Kisunla for Alzheimer's disease in neurology. Lilly is also working on oral incretin-based therapies and next-generation obesity drugs.

Themes watched for Lilly stock include clinical trial results, drug approval processes, investment in manufacturing capacity, drug pricing policies in the US and competing obesity treatments. The LLY page on Lzzo.com presents the price in US dollars together with a historical chart and technical indicators; the source of the price and the time of the last update are also visible.